Price$17.67-0.01 (-0.08%)
01:30 PM07:45 PM
News · 26 weeks53-42%
2025-10-262026-04-19
Mix2490d
- Insider9(38%)
- SEC Filings8(33%)
- Other4(17%)
- Earnings3(13%)
Latest news
25 items- PRProgyny, Inc. Announces Details for Its First Quarter 2026 Results ReportNEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period ended March 31, 2026, after the close of the market on Thursday, May 7, 2026. The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode. An
- INSIDERSEC Form 4 filed by Cummings Melissa B4 - Progyny, Inc. (0001551306) (Issuer)
- PRProgyny Expands Access to Fertility and Women's Health with Industry's First Fully Insured Supplemental PlanNEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, today announces Progyny Select, the industry's first fully insured, comprehensive supplemental fertility and family building plan. Available in the U.S., Progyny Select enables small employers to have access to fertility solutions in a fixed premium model. As the rate of infertility continues to rise and national attention on fertility coverage accelerates, the company is helping to make family building and women's health a standard of care, not a privilege. "Progyny Select is a game-changer for small employers," said Pete Anevski, CEO of Progyny. "We'
- SECSEC Form DEFA14A filed by Progyny Inc.DEFA14A - Progyny, Inc. (0001551306) (Filer)
- SECSEC Form DEF 14A filed by Progyny Inc.DEF 14A - Progyny, Inc. (0001551306) (Filer)
- PRProgyny Commemorates 10 Years of Redefining Women's Health and Family Building CareNEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- Over the past ten years, millions of individuals and families have gained access to life-changing benefits through Progyny, a global leader in women's health and family building solutions. Progyny today announces that throughout the year, it will honor the collective efforts of its members, employers, providers, and industry partners who have helped shape this decade of progress. The company has redefined what's possible in the benefits industry by combining clinical expertise, innovation, and a personalized approach to support members at every stage, from preconception through menopause. "Ten years ago, we set out to transform family building
- SECSEC Form PRE 14A filed by Progyny Inc.PRE 14A - Progyny, Inc. (0001551306) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Progyny Inc.SCHEDULE 13G/A - Progyny, Inc. (0001551306) (Subject)
- INSIDERSEC Form 4 filed by Clapp Geoffrey4 - Progyny, Inc. (0001551306) (Issuer)
- SECProgyny Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Progyny, Inc. (0001551306) (Filer)
- INSIDEREVP, GC Swartz Allison covered exercise/tax liability with 339 shares and sold $10,506 worth of shares (599 units at $17.54), decreasing direct ownership by 1% to 88,941 units (SEC Form 4)4 - Progyny, Inc. (0001551306) (Issuer)
- INSIDERCHIEF FINANCIAL OFFICER Livingston Mark S. covered exercise/tax liability with 339 shares, decreasing direct ownership by 0.39% to 87,338 units (SEC Form 4)4 - Progyny, Inc. (0001551306) (Issuer)
- PRProgyny, Inc. Executives to Participate in Upcoming Investor ConferencesNEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, today announced that several members of its leadership team will participate in upcoming investor conferences in March, including the Leerink Partners Global Healthcare Conference, the Barclays Global Healthcare Conference, and the KeyBanc Capital Markets Healthcare Forum. At the Leerink Partners Global Healthcare Conference, Mark Livingston, Chief Financial Officer, will participate in a fireside chat on March 10, 2026, at 10:40 a.m. Eastern Time. At the Barclays Global Healthcare Conference, Pete Anevski, Chief Executive Officer, will participate in
- INSIDERChief Product Officer Clapp Geoffrey was granted 35,228 shares, increasing direct ownership by 123% to 63,922 units (SEC Form 4)4 - Progyny, Inc. (0001551306) (Issuer)
- INSIDERChief Operating Officer Cummings Melissa B was granted 45,454 shares, increasing direct ownership by 109% to 87,121 units (SEC Form 4)4 - Progyny, Inc. (0001551306) (Issuer)
- INSIDEREVP, GC Swartz Allison was granted 28,409 shares, covered exercise/tax liability with 4,393 shares and sold $119,007 worth of shares (6,856 units at $17.36), increasing direct ownership by 24% to 89,879 units (SEC Form 4)4 - Progyny, Inc. (0001551306) (Issuer)
- INSIDERCHIEF FINANCIAL OFFICER Livingston Mark S. was granted 45,454 shares and covered exercise/tax liability with 4,760 shares, increasing direct ownership by 87% to 87,677 units (SEC Form 4)4 - Progyny, Inc. (0001551306) (Issuer)
- INSIDERCHIEF EXECUTIVE OFFICER Anevski Peter was granted 159,091 shares and covered exercise/tax liability with 17,611 shares, increasing direct ownership by 21% to 816,833 units (SEC Form 4)4 - Progyny, Inc. (0001551306) (Issuer)
- SECSEC Form 144 filed by Progyny Inc.144 - Progyny, Inc. (0001551306) (Subject)
- SECSEC Form S-8 filed by Progyny Inc.S-8 - Progyny, Inc. (0001551306) (Filer)
- SECSEC Form 10-K filed by Progyny Inc.10-K - Progyny, Inc. (0001551306) (Filer)
- SECProgyny Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Progyny, Inc. (0001551306) (Filer)
- PRProgyny, Inc. Announces Fourth Quarter 2025 ResultsReports Revenue of $318.4 Million, Reflecting Fourth Quarter Growth of 6.7% and 10% for the Full YearGenerated Record $210.2 Million in Full Year Operating Cash FlowReturned Value to Shareholders Through Repurchase of Approximately 6.5 Million Shares To Date Under Recent AuthorizationIssues Financial Guidance for 2026, Reflecting Tenth Consecutive Year of Revenue Growth NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a global leader in women's health and family building solutions, today announced its financial results for the three- and twelve-month periods ended December 31, 2025 ("the fourth quarter of 2025" and "the full year", resp
- PRProgyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results ReportNEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period and full year ended December 31, 2025, after the close of the market on Thursday, February 26, 2026. The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using t
- ANALYSTProgyny upgraded by Citizens JMP with a new price targetCitizens JMP upgraded Progyny from Mkt Perform to Mkt Outperform and set a new price target of $30.00